UK's Government and Industry in drug price deal
- Details
- Category: Research
A new deal has been reached between the UK's Government and the pharmaceutical industry means that more patients will benefit from a wider range of innovative drug treatments at a fair price to the NHS. The flexible pricing scheme agreed will ensure that medicines fairly reflect their value to patients, branded drugs will see their price cut, and industry innovations will be encouraged and rewarded.
Manhattan Research Releases Report on the Future of Physician Customer Service Portals
- Details
- Category: Research
Over the past year, physician visitation to customer service portals decreased while interest in using them actually increased. To help biopharma companies bridge the gap between the current portal landscape and unmet physician demand, pharmaceutical and healthcare market research company Manhattan Research just released its latest physician module report, "The Case for Customer Care: Service Portals and a Successfully Integrated CRM System" as part of its ePharma Physicianâ v8.0 market research and strategic advisory service.
EU project IMMIDIET warns: control hypertension in Europe
- Details
- Category: Research
An EU-funded population study has shown that hypertension, an important risk factor for cardiovascular disease, is a serious problem in Europe. The results of the IMMIDIET project indicate that high blood pressure has become more common in Italy than in England or Belgium, a reversal of the commonly accepted trend.
New drug protects against diet-induced obesity and diabetes
- Details
- Category: Research
A recent EU-funded study by a Swiss-led international team of researchers has found that a new synthetic drug, developed by researchers in the US, protects against diet-induced obesity. At the same time, it improves glucose tolerance and insulin sensitivity and increases exercise endurance by enhancing fat utilisation in certain tissues.
Manhattan Research reports that the number of Health 2.0 consumers has doubled since 2007
- Details
- Category: Research
Over 60 million U.S. adults are Health 2.0 consumers - reporting to use health blogs, online support groups, prescription rating sites, and other health-related social media applications, according to pharmaceutical and healthcare market research company Manhattan Research's just released Cybercitizen Health™ v8.0 consumer study and strategic advisory service.
New finding could lead to development of hundreds of new antibiotics
- Details
- Category: Research
EU-funded scientists have discovered a new molecule in Streptomyces bacteria that could be exploited to make the bacteria produce hundreds of novel antibiotics. The work, which is published online by the Proceedings of the National Academy of Sciences (PNAS), was partly supported by the EU-funded ACTINOGEN (Integrating genomics-based applications to exploit actinomycetes as a resource for new antibiotics) project.
Heinrich Wieland Prize: Closing in on the cause of diabetes
- Details
- Category: Research
For his milestone discoveries on the development of diabetes, Prof. Markus Stoffel from the Institute of Molecular Systems Biology at the ETH Zurich was awarded the Heinrich Wieland Prize, one of the most treasured science awards in Germany. He received the distinction with EUR 50,000 prize money for his work in deciphering important mechanisms of blood sugar regulation and lipid metabolism in the body.
More Pharma News ...
- InforSense Collaborates with Industry Innovators to Enable Virtual Drug Discovery
- Research agreement for the development of insulin-producing cells from human stem cells
- A new journal where molecular biology meets clinical research
- EMEA half-year report for 2008 shows activities to be on target
- New Media Offers Cost-Efficient Ways to Reach and Engage Targets
- Medicines regulators on both sides of the Atlantic confirm commitment to cooperation on medicines
- Philips develops ultrasound-activated microbubbles for localized delivery of cancer drugs